vs
Healthpeak Properties（DOC）与Tempus AI, Inc.（TEM）财务数据对比。点击上方公司名可切换其他公司
Healthpeak Properties的季度营收约是Tempus AI, Inc.的2.0倍（$719.4M vs $367.2M），Healthpeak Properties净利率更高（73.2% vs -14.8%，领先87.9%），Tempus AI, Inc.同比增速更快（83.0% vs 3.1%），Healthpeak Properties自由现金流更多（$357.0M vs $-41.5M），过去两年Tempus AI, Inc.的营收复合增速更高（58.7% vs 8.9%）
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
Tempus AI是2015年由埃里克·莱夫科夫斯基在美国伊利诺伊州芝加哥创立的医疗科技企业，创立契机源于其妻子确诊乳腺癌。公司依托数据与人工智能技术，为肿瘤、心脏病、放射医学、抑郁症等领域提供包含诊断在内的精准医疗服务，2024年6月14日于纳斯达克上市，股票代码为TEM。
DOC vs TEM — 直观对比
营收规模更大
DOC
是对方的2.0倍
$367.2M
营收增速更快
TEM
高出79.9%
3.1%
净利率更高
DOC
高出87.9%
-14.8%
自由现金流更多
DOC
多$398.6M
$-41.5M
两年增速更快
TEM
近两年复合增速
8.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $719.4M | $367.2M |
| 净利润 | $114.0M | $-54.2M |
| 毛利率 | — | — |
| 营业利润率 | 17.4% | -16.7% |
| 净利率 | 73.2% | -14.8% |
| 营收同比 | 3.1% | 83.0% |
| 净利润同比 | 2406.4% | -316.2% |
| 每股收益（稀释后） | $0.16 | $-0.30 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCTEM
| Q4 25 | $719.4M | $367.2M | ||
| Q3 25 | $705.9M | $334.2M | ||
| Q2 25 | $694.3M | $314.6M | ||
| Q1 25 | $702.9M | $255.7M | ||
| Q4 24 | $698.0M | $200.7M | ||
| Q3 24 | $700.4M | $180.9M | ||
| Q2 24 | $695.5M | $166.0M | ||
| Q1 24 | $606.6M | $145.8M |
净利润DOCTEM
| Q4 25 | $114.0M | $-54.2M | ||
| Q3 25 | $-117.1M | $-80.0M | ||
| Q2 25 | $31.7M | $-42.8M | ||
| Q1 25 | $42.8M | $-68.0M | ||
| Q4 24 | $4.5M | $-13.0M | ||
| Q3 24 | $85.9M | $-75.8M | ||
| Q2 24 | $146.0M | $-552.2M | ||
| Q1 24 | $6.7M | $-64.7M |
毛利率DOCTEM
| Q4 25 | — | — | ||
| Q3 25 | 58.6% | — | ||
| Q2 25 | 60.2% | — | ||
| Q1 25 | 61.1% | — | ||
| Q4 24 | 60.3% | — | ||
| Q3 24 | 60.0% | — | ||
| Q2 24 | 60.6% | — | ||
| Q1 24 | 59.8% | — |
营业利润率DOCTEM
| Q4 25 | 17.4% | -16.7% | ||
| Q3 25 | 9.2% | -18.3% | ||
| Q2 25 | 5.7% | -19.6% | ||
| Q1 25 | 7.7% | -26.9% | ||
| Q4 24 | -2.2% | -25.3% | ||
| Q3 24 | 14.1% | -29.6% | ||
| Q2 24 | 22.3% | -321.4% | ||
| Q1 24 | 3.7% | -36.5% |
净利率DOCTEM
| Q4 25 | 73.2% | -14.8% | ||
| Q3 25 | -16.6% | -23.9% | ||
| Q2 25 | 4.6% | -13.6% | ||
| Q1 25 | 6.1% | -26.6% | ||
| Q4 24 | 0.7% | -6.5% | ||
| Q3 24 | 12.3% | -41.9% | ||
| Q2 24 | 21.0% | -332.7% | ||
| Q1 24 | 1.1% | -44.4% |
每股收益（稀释后）DOCTEM
| Q4 25 | $0.16 | $-0.30 | ||
| Q3 25 | $-0.17 | $-0.46 | ||
| Q2 25 | $0.05 | $-0.25 | ||
| Q1 25 | $0.06 | $-0.40 | ||
| Q4 24 | $0.02 | $2.56 | ||
| Q3 24 | $0.12 | $-0.46 | ||
| Q2 24 | $0.21 | $-6.86 | ||
| Q1 24 | $0.01 | $-1.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $467.5M | $604.8M |
| 总债务越低越好 | $9.8B | — |
| 股东权益账面价值 | $7.5B | $491.3M |
| 总资产 | $20.3B | $2.3B |
| 负债/权益比越低杠杆越低 | 1.31× | — |
8季度趋势，按日历期对齐
现金及短期投资DOCTEM
| Q4 25 | $467.5M | $604.8M | ||
| Q3 25 | $91.0M | $655.9M | ||
| Q2 25 | $89.4M | $186.3M | ||
| Q1 25 | $70.6M | $151.6M | ||
| Q4 24 | $119.8M | $341.0M | ||
| Q3 24 | $180.4M | $388.0M | ||
| Q2 24 | $106.9M | $478.8M | ||
| Q1 24 | $101.8M | $79.9M |
总债务DOCTEM
| Q4 25 | $9.8B | — | ||
| Q3 25 | $9.1B | — | ||
| Q2 25 | $9.0B | — | ||
| Q1 25 | $8.9B | — | ||
| Q4 24 | $8.7B | — | ||
| Q3 24 | $8.6B | — | ||
| Q2 24 | $8.6B | — | ||
| Q1 24 | $8.8B | — |
股东权益DOCTEM
| Q4 25 | $7.5B | $491.3M | ||
| Q3 25 | $7.6B | $507.8M | ||
| Q2 25 | $7.9B | $309.6M | ||
| Q1 25 | $8.2B | $326.2M | ||
| Q4 24 | $8.4B | $56.3M | ||
| Q3 24 | $8.6B | $53.7M | ||
| Q2 24 | $8.8B | $98.3M | ||
| Q1 24 | $8.9B | $-1.5B |
总资产DOCTEM
| Q4 25 | $20.3B | $2.3B | ||
| Q3 25 | $19.6B | $2.3B | ||
| Q2 25 | $19.8B | $1.6B | ||
| Q1 25 | $19.8B | $1.5B | ||
| Q4 24 | $19.9B | $926.1M | ||
| Q3 24 | $20.0B | $971.7M | ||
| Q2 24 | $20.2B | $864.6M | ||
| Q1 24 | $20.5B | — |
负债/权益比DOCTEM
| Q4 25 | 1.31× | — | ||
| Q3 25 | 1.20× | — | ||
| Q2 25 | 1.14× | — | ||
| Q1 25 | 1.08× | — | ||
| Q4 24 | 1.04× | — | ||
| Q3 24 | 1.00× | — | ||
| Q2 24 | 0.98× | — | ||
| Q1 24 | 0.99× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.3B | $-36.8M |
| 自由现金流经营现金流 - 资本支出 | $357.0M | $-41.5M |
| 自由现金流率自由现金流/营收 | 49.6% | -11.3% |
| 资本支出强度资本支出/营收 | 124.4% | 1.3% |
| 现金转化率经营现金流/净利润 | 10.99× | — |
| 过去12个月自由现金流最近4个季度 | — | $-239.1M |
8季度趋势，按日历期对齐
经营现金流DOCTEM
| Q4 25 | $1.3B | $-36.8M | ||
| Q3 25 | $315.0M | $-119.8M | ||
| Q2 25 | $363.5M | $44.2M | ||
| Q1 25 | $279.4M | $-105.6M | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $318.2M | $48.7M | ||
| Q2 24 | $316.2M | $-97.1M | ||
| Q1 24 | $152.6M | $-101.4M |
自由现金流DOCTEM
| Q4 25 | $357.0M | $-41.5M | ||
| Q3 25 | — | $-126.5M | ||
| Q2 25 | — | $36.6M | ||
| Q1 25 | — | $-107.7M | ||
| Q4 24 | $333.7M | — | ||
| Q3 24 | — | $48.6M | ||
| Q2 24 | — | $-105.1M | ||
| Q1 24 | — | $-107.5M |
自由现金流率DOCTEM
| Q4 25 | 49.6% | -11.3% | ||
| Q3 25 | — | -37.9% | ||
| Q2 25 | — | 11.6% | ||
| Q1 25 | — | -42.1% | ||
| Q4 24 | 47.8% | — | ||
| Q3 24 | — | 26.9% | ||
| Q2 24 | — | -63.3% | ||
| Q1 24 | — | -73.7% |
资本支出强度DOCTEM
| Q4 25 | 124.4% | 1.3% | ||
| Q3 25 | — | 2.0% | ||
| Q2 25 | — | 2.4% | ||
| Q1 25 | — | 0.8% | ||
| Q4 24 | 105.6% | — | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 4.8% | ||
| Q1 24 | — | 4.2% |
现金转化率DOCTEM
| Q4 25 | 10.99× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 11.48× | — | ||
| Q1 25 | 6.52× | — | ||
| Q4 24 | 235.43× | — | ||
| Q3 24 | 3.71× | — | ||
| Q2 24 | 2.17× | — | ||
| Q1 24 | 22.85× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
